Skip to content
Home/Companies/Biotech/Alcolase

Alcolase

Biotech·Denmark·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Alcolase?

Alcolase is currently owned by Delphinus Venture Capital through Delphinus Evergreen Fund (2025 vintage), since 2026.

Hand-verified · updated 2026-08-19

Delphinus Venture Capital
Investor
Delphinus Venture Capital
Delphinus Evergreen Fund · 2025 · VC

Key facts

HQDenmark
SectorBiotech
StatusActive

More from Delphinus Evergreen Fund

Other portfolio companies in the same fund.

Ardos
Active
MedTechDenmark· 2026
Cordulus
Active
AgTechDenmark· 2026
Cystotech
Active
MedTechDenmark· 2026
Decameal
Active
FoodTechDenmark· 2026
EtOH Spirits
Active
FoodTechDenmark· 2026
Kvantify
Active
BiotechDenmark· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Alcolase

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Alcolase?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Alcolase.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue